Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ginkgo Bioworks Holdings, Inc. (DNA)

3.12   -0.01 (-0.32%) 10-02 21:43
Open: 3.12 Pre. Close: 3.13
High: 3.41 Low: 3.09
Volume: 28,130,986 Market Cap: 5,851(M)
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.41 - 3.43 3.43 - 3.45
Low: 3.05 - 3.07 3.07 - 3.09
Close: 3.09 - 3.12 3.12 - 3.15

Technical analysis

as of: 2022-09-30 4:27:30 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.07     One year: 4.76
Support: Support1: 2.78    Support2: 2.34
Resistance: Resistance1: 3.49    Resistance2: 4.07
Pivot: 3.02
Moving Average: MA(5): 3.08     MA(20): 2.93
MA(100): 2.92     MA(250): 5.58
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 70.3     %D(3): 67.1
RSI: RSI(14): 53.6
52-week: High: 15.86  Low: 2.08
Average Vol(K): 3-Month: 25,090 (K)  10-Days: 25,348 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ DNA ] has closed below upper band by 35.8%. Bollinger Bands are 40.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 02 Oct 2022
Studying yeast DNA in space may help protect astronauts from cosmic radiation - The Conversation

Sun, 02 Oct 2022
A transition phase in late mouse oogenesis impacts DNA methylation of the early embryo | Communications Biology -

Sat, 01 Oct 2022
Newsom Signs Bill to Protect Sexual Assault Victims' DNA - NBC Bay Area

Sat, 01 Oct 2022
How police can use your DNA to solve crimes without consent - New York Post

Fri, 30 Sep 2022
COVID Attacks DNA in Heart, Unlike Flu, Study Says - WebMD

Fri, 30 Sep 2022
Illumina pitches $200 genomes with new line of DNA sequencers - FierceBiotech

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 1,190 (M)
Shares Float 790 (M)
% Held by Insiders 6 (%)
% Held by Institutions 77.6 (%)
Shares Short 179,060 (K)
Shares Short P.Month 150,270 (K)

Stock Financials

EPS -1.68
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.93
Profit Margin (%) 0
Operating Margin (%) -562.5
Return on Assets (ttm) -146.9
Return on Equity (ttm) -309
Qtrly Rev. Growth 231.3
Gross Profit (p.s.) 0.15
Sales Per Share 0.45
EBITDA (p.s.) -2.53
Qtrly Earnings Growth 0
Operating Cash Flow -290 (M)
Levered Free Cash Flow 904 (M)

Stock Valuations

PE Ratio -1.87
PEG Ratio 0
Price to Book value 3.31
Price to Sales 6.88
Price to Cash Flow -12.81

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.